Vesikari T et al. |
Assessment of squalene adjuvanted and non-adjuvanted vaccines against pandemic H1N1 influenza in children 6 months to 17 years of age. |
2012 |
Hum Vaccin Immunother |
pmid:22906943
|
Della Cioppa G et al. |
Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59 (®) adjuvant: results from a dose-finding clinical trial in older adults. |
2012 |
Hum Vaccin Immunother |
pmid:22426371
|
Ikematsu H et al. |
Evaluation of immune response following one dose of an AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older. |
2012 |
Hum Vaccin Immunother |
pmid:22854661
|
Siegrist CA et al. |
Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine. |
2012 |
Antivir. Ther. (Lond.) |
pmid:22544169
|
Yang M et al. |
MF59 formulated with CpG ODN as a potent adjuvant of recombinant HSP65-MUC1 for inducing anti-MUC1+ tumor immunity in mice. |
2012 |
Int. Immunopharmacol. |
pmid:22595192
|
Cabrera-Vique C et al. |
Bioactive compounds and nutritional significance of virgin argan oil--an edible oil with potential as a functional food. |
2012 |
Nutr. Rev. |
pmid:22537213
|
Stella B et al. |
Nonpolymeric nanoassemblies for ocular administration of acyclovir: pharmacokinetic evaluation in rabbits. |
2012 |
Eur J Pharm Biopharm |
pmid:22008147
|
Nakazawa A et al. |
Optimization of culture conditions of the thraustochytrid Aurantiochytrium sp. strain 18W-13a for squalene production. |
2012 |
Bioresour. Technol. |
pmid:22023965
|
Niehaus TD et al. |
Functional identification of triterpene methyltransferases from Botryococcus braunii race B. |
2012 |
J. Biol. Chem. |
pmid:22241476
|
Iorio AM et al. |
Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus. |
2012 |
Vaccine |
pmid:22245606
|
Ambrose CS and Belshe RB |
Influenza vaccine in young children. |
2012 |
N. Engl. J. Med. |
pmid:22276839
|
Heikkinen T and Heinonen S |
Influenza vaccine in young children. |
2012 |
N. Engl. J. Med. |
pmid:22276840
|
Gasparini R et al. |
Aflunov(®): a prepandemic influenza vaccine. |
2012 |
Expert Rev Vaccines |
pmid:22309663
|
Langley JM et al. |
Randomized, multicenter trial of a single dose of AS03-adjuvanted or unadjuvanted H1N1 2009 pandemic influenza vaccine in children 6 months to <9 years of age: safety and immunogenicity. |
2012 |
Pediatr. Infect. Dis. J. |
pmid:22801094
|
Block SL et al. |
Dose-range study of MF59-adjuvanted versus nonadjuvanted monovalent A/H1N1 pandemic influenza vaccine in six- to less than thirty-six-month-old children. |
2012 |
Pediatr. Infect. Dis. J. |
pmid:22481427
|
Sémiramoth N et al. |
Self-assembled squalenoylated penicillin bioconjugates: an original approach for the treatment of intracellular infections. |
2012 |
ACS Nano |
pmid:22482704
|
Langley JM et al. |
Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study. |
2012 |
Vaccine |
pmid:22469860
|
Fukase H et al. |
Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects. |
2012 |
Vaccine |
pmid:22472791
|
Suthiwong J et al. |
A new phenolic compound from the stem of Hymenocardia wallichii. |
2012 |
J Asian Nat Prod Res |
pmid:22423644
|
Zhang XH et al. |
Chemical composition of volatile oils from the pericarps of Indian sandalwood (Santalum album) by different extraction methods. |
2012 |
Nat Prod Commun |
pmid:22428257
|
Guzmán Herrador BR et al. |
Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway. |
2012 |
BMC Infect. Dis. |
pmid:22429643
|
Hatz C et al. |
A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects. |
2012 |
Vaccine |
pmid:22446638
|
Lai RP et al. |
Mixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvants. |
2012 |
PLoS ONE |
pmid:22509385
|
Marinaro M et al. |
A caprine herpesvirus 1 vaccine adjuvanted with MF59â„¢ protects against vaginal infection and interferes with the establishment of latency in goats. |
2012 |
PLoS ONE |
pmid:22511971
|
Reynales H et al. |
A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemic. |
2012 |
Vaccine |
pmid:22902681
|
Desmaële D et al. |
Squalenoylation: a generic platform for nanoparticular drug delivery. |
2012 |
J Control Release |
pmid:21840355
|
Naziri E et al. |
Recovery of squalene from wine lees using ultrasound assisted extraction-a feasibility study. |
2012 |
J. Agric. Food Chem. |
pmid:22888984
|
Czajka H et al. |
A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects. |
2012 |
J Prev Med Hyg |
pmid:23362618
|
Takami T et al. |
A genetic and pharmacological analysis of isoprenoid pathway by LC-MS/MS in fission yeast. |
2012 |
PLoS ONE |
pmid:23145048
|
Langley JM et al. |
A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine. |
2012 |
BMC Infect. Dis. |
pmid:23110320
|
Bihari I et al. |
Assessment of antigen-specific and cross-reactive antibody responses to an MF59-adjuvanted A/H5N1 prepandemic influenza vaccine in adult and elderly subjects. |
2012 |
Clin. Vaccine Immunol. |
pmid:23081815
|
Tetsutani K and Ishii KJ |
Adjuvants in influenza vaccines. |
2012 |
Vaccine |
pmid:23084848
|
Liu YT et al. |
Protein engineering of Saccharomyces cerevisiae oxidosqualene-lanosterol cyclase into parkeol synthase. |
2012 |
Org. Lett. |
pmid:23043506
|
Dorea JG |
Safety of thimerosal in vaccines: for whom and how many doses? |
2011 Mar-Apr |
Therapie |
pmid:23189333
|
Kozlov VG and Viktorova EG |
[Evaluation of the efficiency and reactogenicity of emulsion-based adjuvant systems in the manufacture of polyclonal enteroviral diagnostic sera]. |
2011 Mar-Apr |
Vopr. Virusol. |
pmid:21545042
|
Durando P et al. |
Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine. |
2011 Jan-Feb |
Hum Vaccin |
pmid:21245655
|
Schellenberger MT et al. |
Evaluation of adjuvants for a candidate conjugate vaccine against benzo[a]pyrene. |
2011 Jan-Feb |
Hum Vaccin |
pmid:21245662
|
van den Brand JM et al. |
Efficacy of vaccination with different combinations of MF59-adjuvanted and nonadjuvanted seasonal and pandemic influenza vaccines against pandemic H1N1 (2009) influenza virus infection in ferrets. |
2011 |
J. Virol. |
pmid:21209108
|
Calabro S et al. |
Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. |
2011 |
Vaccine |
pmid:21215831
|
Javelle E et al. |
Delayed focal lipoatrophy after AS03-adjuvanted influenza A (H1N1) 2009 vaccine. |
2011 |
Vaccine |
pmid:21172376
|
Montagnani S et al. |
Autoimmune hemolytic anemia following MF59-adjuvanted influenza vaccine administration: a report of two cases. |
2011 |
Ann Pharmacother |
pmid:21189364
|
Esposito S et al. |
Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents. |
2011 |
Vaccine |
pmid:21199699
|
Fabbiani M et al. |
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients. |
2011 |
Vaccine |
pmid:21349364
|
Gill S et al. |
Cholesterol-dependent degradation of squalene monooxygenase, a control point in cholesterol synthesis beyond HMG-CoA reductase. |
2011 |
Cell Metab. |
pmid:21356516
|
Brito LA et al. |
An alternative renewable source of squalene for use in emulsion adjuvants. |
2011 |
Vaccine |
pmid:21723355
|
Cauda V et al. |
"Liquid-phase calcination" of colloidal mesoporous silica nanoparticles in high-boiling solvents. |
2011 |
J. Am. Chem. Soc. |
pmid:21480591
|
Griffiths PD et al. |
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. |
2011 |
Lancet |
pmid:21481708
|
Liu CL et al. |
The direct observation of secondary radical chain chemistry in the heterogeneous reaction of chlorine atoms with submicron squalane droplets. |
2011 |
Phys Chem Chem Phys |
pmid:21455529
|
Inagaki YS et al. |
Investigation of the potential for triterpene synthesis in rice through genome mining and metabolic engineering. |
2011 |
New Phytol. |
pmid:21501172
|
Garcia-Sicilia J et al. |
Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents. |
2011 |
Vaccine |
pmid:21504774
|